In March 2025, the company declared new programs to get a immediate-to-client giving of its Wegovy weight loss drug. The company established a completely new pharmacy, referred to as NovoCare, which might demand clients $499 every month for use of the drug, lower than half the price of the drug through other pharmaceutical distribution networks.[53